Çağlayan Biçer
Çağlayan Biçer has a total of 34 co-authors. Here are the top co-authors by number of shared publications:
Fatih Akkuş
2 shared publications- Serhan Can İsCan
Kütahya Health Sciences University
2 shared publications - Abdulmecit Öktem
Department of Perinatology, Health Sciences University, City Hospital of Izmir, Izmir 35540, Turkey
1 shared publication - Atiye Seda Yar Sağlam
Department of Medical Biology, Faculty of Medicine Gazi University Ankara Türkiye
1 shared publication - Aybike Tazegül Pekin
Department of Perinatology, Selcuk University Faculty of Medicine, Konya, Turkey
1 shared publication - Ceren Sağlam Purut
Department of Perinatology, İzmir Atatürk Training and Research Hospital, 35360 İzmir, Türkiye
1 shared publication
Latest Publications
- Open Access
- 30 September 2026
- Published by Cukurova Anestezi ve Cerrahi Bilimler Dergisi in Cukurova Anestezi ve Cerrahi Bilimler Dergisi
- Vol. 9 (3) , 1063-1073
Association between preoperative primary tumor SUVmax on FDG PET-CT and high-risk pathological features for the prediction of lymph node metastases in endometrial cancer
Aim:To evaluate the association between preoperative primary tumor SUVmax on 18F-FDG PET-CT and lymph node metastasis, and to assess its relationship with high-risk pathological features in surgically staged endometrial cancer patients.Materials and Methods: In this retrospective cohort study, 134 patients with histologically confirmed endometrial cancer who underwent preoperative 18F-FDG PET-CT and primary surgical staging were included. Primary tumor SUVmax, clinical, imaging, and histopathological parameters were compared between patients with and without lymph node metastasis. ROC curve analysis and univariable/multivariable logistic regression were performed to identify predictors of nodal metastasis.Results:Lymph node metastasis was present in 16 patients (11.9%). Median SUVmax was significantly higher in the lymph-node-positive group (22.60 vs. 14.56; p = 0.003). SUVmax showed moderate discrimination for lymph node metastasis (AUC 0.733; optimal cutoff ≥21.10; sensitivity 62.5%, specificity 79.7%, negative predictive value 94.0%). Pathological tumor diameter showed the numerically highest AUC (0.822), though DeLong's test revealed no significant pairwise differences among ROC curves. On univariable analysis, SUVmax, tumor diameter, CA125, high grade, non-endometrioid histology, LVSI, deep myometrial invasion, and cervical involvement were significantly associated with nodal metastasis. In the exploratory multivariable model, LVSI remained independently associated (adjusted OR 14.33; p = 0.001), while SUVmax (p = 0.182) and deep myometrial invasion (p = 0.094) lost statistical significance.Conclusion: Primary tumor SUVmax is significantly associated with lymph node metastasis and correlates with high-risk pathological features in endometrial cancer, with a high negative predictive value supporting its role in preoperative risk stratification. While LVSI appeared as the most significant predictor overall, it can only be determined after surgery; in contrast, SUVmax, which is accessible preoperatively, could function as a therapeutically relevant proxy for recognizing high-risk individuals prior to the operation. Larger prospective research is required for confirmation.
- 30 September 2026
- Published by Cukurova Anestezi ve Cerrahi Bilimler Dergisi in Cukurova Anestezi ve Cerrahi Bilimler Dergisi
- Vol. 9 (3) , 1063-1073
Open AccessAssociation between preoperative primary tumor SUVmax on FDG PET-CT and high-risk pathological features for the prediction of lymph node metastases in endometrial cancer
Aim:To evaluate the association between preoperative primary tumor SUVmax on 18F-FDG PET-CT and lymph node metastasis, and to assess its relationship with high-risk pathological features in surgically staged endometrial cancer patients.Materials and Methods: In this retrospective cohort study, 134 patients with histologically confirmed endometrial cancer who underwent preoperative 18F-FDG PET-CT and primary surgical staging were included. Primary tumor SUVmax, clinical, imaging, and histopathological parameters were compared between patients with and without lymph node metastasis. ROC curve analysis and univariable/multivariable logistic regression were performed to identify predictors of nodal metastasis.Results:Lymph node metastasis was present in 16 patients (11.9%). Median SUVmax was significantly higher in the lymph-node-positive group (22.60 vs. 14.56; p = 0.003). SUVmax showed moderate discrimination for lymph node metastasis (AUC 0.733; optimal cutoff ≥21.10; sensitivity 62.5%, specificity 79.7%, negative predictive value 94.0%). Pathological tumor diameter showed the numerically highest AUC (0.822), though DeLong's test revealed no significant pairwise differences among ROC curves. On univariable analysis, SUVmax, tumor diameter, CA125, high grade, non-endometrioid histology, LVSI, deep myometrial invasion, and cervical involvement were significantly associated with nodal metastasis. In the exploratory multivariable model, LVSI remained independently associated (adjusted OR 14.33; p = 0.001), while SUVmax (p = 0.182) and deep myometrial invasion (p = 0.094) lost statistical significance.Conclusion: Primary tumor SUVmax is significantly associated with lymph node metastasis and correlates with high-risk pathological features in endometrial cancer, with a high negative predictive value supporting its role in preoperative risk stratification. While LVSI appeared as the most significant predictor overall, it can only be determined after surgery; in contrast, SUVmax, which is accessible preoperatively, could function as a therapeutically relevant proxy for recognizing high-risk individuals prior to the operation. Larger prospective research is required for confirmation.
- Open Access
- 13 May 2026
- Published by JMIR Publications Inc. in JMIR Preprints
Quality and Safety of YouTube Videos on GLP-1 Receptor Agonists and Reproductive Health: A Systematic Evaluation Using Validated Instruments and Artificial Intelligence (Preprint)
BACKGROUND GLP-1 receptor agonists (GLP-1 RAs) — semaglutide, liraglutide, and tirzepatide — are among the most widely prescribed medications globally, with disproportionate uptake among women of reproductive age. The quality of YouTube content on GLP-1 RAs and reproductive health has not been previously characterized. OBJECTIVE This study aimed to evaluate the quality, accuracy, and misinformation burden of YouTube videos addressing GLP-1 RAs in a reproductive health context, and to assess the validity of large language model (LLM)-assisted quality scoring as a scalable surveillance tool. METHODS We conducted a PRISMA-compliant cross-sectional analysis of 137 YouTube videos retrieved via YouTube Data API v3 on 8 March 2026. Two physicians independently scored each video using four validated instruments: Global Quality Scale (GQS, 1-5), modified DISCERN (mDISCERN, 0-5), JAMA Benchmark Criteria (0-4), and a 3-point Medical Accuracy Scale. Videos were classified Useful or Misleading by consensus. A large language model (Claude Sonnet; temperature = 0) independently scored all videos blinded to human ratings. RESULTS Overall quality was below acceptable (GQS 2.60 ± 1.04; 65.7% scored below 3); 22.6% (n = 31) were classified Misleading. Short videos (≤ 180 s; 54.7%) had the lowest mean GQS (1.95) and the highest misinformation rate (29%). ROC analysis identified 212 s as the optimal quality threshold (AUC = 0.892). Off-label content carried the highest misinformation rate (73%); preconception discontinuation protocols were absent from 61% of videos. Engagement metrics were uncorrelated with quality (ρ = −0.141). The LLM showed strong rank-order agreement with human raters (GQS ρ = 0.845; mDISCERN ρ = 0.840) but exhibited systematic upward score inflation. CONCLUSIONS YouTube content on GLP-1 RAs and reproductive health is predominantly poor quality and frequently misleading. Short-format videos pose the greatest patient safety risk, critical preconception information is frequently absent, and viral reach does not select for accuracy. LLM-assisted evaluation is valid and scalable for rank-order surveillance but requires expert calibration before operational deployment.
- 13 May 2026
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessQuality and Safety of YouTube Videos on GLP-1 Receptor Agonists and Reproductive Health: A Systematic Evaluation Using Validated Instruments and Artificial Intelligence (Preprint)
BACKGROUND GLP-1 receptor agonists (GLP-1 RAs) — semaglutide, liraglutide, and tirzepatide — are among the most widely prescribed medications globally, with disproportionate uptake among women of reproductive age. The quality of YouTube content on GLP-1 RAs and reproductive health has not been previously characterized. OBJECTIVE This study aimed to evaluate the quality, accuracy, and misinformation burden of YouTube videos addressing GLP-1 RAs in a reproductive health context, and to assess the validity of large language model (LLM)-assisted quality scoring as a scalable surveillance tool. METHODS We conducted a PRISMA-compliant cross-sectional analysis of 137 YouTube videos retrieved via YouTube Data API v3 on 8 March 2026. Two physicians independently scored each video using four validated instruments: Global Quality Scale (GQS, 1-5), modified DISCERN (mDISCERN, 0-5), JAMA Benchmark Criteria (0-4), and a 3-point Medical Accuracy Scale. Videos were classified Useful or Misleading by consensus. A large language model (Claude Sonnet; temperature = 0) independently scored all videos blinded to human ratings. RESULTS Overall quality was below acceptable (GQS 2.60 ± 1.04; 65.7% scored below 3); 22.6% (n = 31) were classified Misleading. Short videos (≤ 180 s; 54.7%) had the lowest mean GQS (1.95) and the highest misinformation rate (29%). ROC analysis identified 212 s as the optimal quality threshold (AUC = 0.892). Off-label content carried the highest misinformation rate (73%); preconception discontinuation protocols were absent from 61% of videos. Engagement metrics were uncorrelated with quality (ρ = −0.141). The LLM showed strong rank-order agreement with human raters (GQS ρ = 0.845; mDISCERN ρ = 0.840) but exhibited systematic upward score inflation. CONCLUSIONS YouTube content on GLP-1 RAs and reproductive health is predominantly poor quality and frequently misleading. Short-format videos pose the greatest patient safety risk, critical preconception information is frequently absent, and viral reach does not select for accuracy. LLM-assisted evaluation is valid and scalable for rank-order surveillance but requires expert calibration before operational deployment.
- 18 April 2025
- Published by Academician Publishing
- p. 139-148
Gebelik ve Hipotiroidizm
- Open Access
- 18 April 2025
- Published by Academician Publishing
Güncel Kadın Hastalıkları ve Doğum Çalışmaları IX (Bahar)
Gebelikte Karaciğer Hastalıkları Abdulmecit ÖKTEM Endometrium Kanseri, Sirkadiyen Ritim ve Kronokemoterapi Yağmur SOYKAN Atiye Seda YAR SAĞLAM Tubal ve Non-Tubal Ektopik Gebelikler Hayal UZELLI ŞIMŞEK Anormal Uterin Kanama Meryem Özge ÇAKIR NEMLİ V-Notes Histerektomi: Minimal İnvaziv Bir Yaklaşım Serhat SARIKAYA Polikistik Over Sendromu Tedavisinde Kullanılma Özelliği Olan Bazı Bitkiler Derya UÇAR Ömer KILIÇ Talip ŞAHİN Tekrarlayan Gebelik Kayıpları: İmmünolojik, Genetik ve Anatomik Faktörler Mehmet Efe NAMLI Fetal Kas-İskelet Sistemi Serhat AKCAN Fetal Santral Sinir Sistemi Serhat AKCAN Gebelik ve Hipotiroidizm Çağlayan BIÇER Fatih AKKUŞ Ektopik Gebelik Selin MUTLU Endometriozis Selin MUTLU Gebelikte Hipertiroidizm; Klinik Bulgular, Tanı ve Tedavi Raziye TORUN Prenatal Kayıp ve Hemşirelik Bakımı Merve YAZAR Gül Büşra ALTUNAY Servikal Yetmezlik İlayda GERCİK ARZIK Korea Gravidarum Hale ANKARA AKTAŞ Gebelik ve Addison Hastalığı İlknur TOKA Konjenital Zika Virüs Enfeksiyonu Ceren SAĞLAM Progesteron Tedavisinin Hormon Düzeyleri ve Solunum Fonksiyonları Üzerindeki Etkileri: Polikistik Over Sendromlu Hastalarda Klinik Bir Çalışma Fikriye KARANFIL Aybike PEKIN Kazım GEZGINÇ Rengin KARATAYLI Emin MADEN Rh İzoimmünizasyonu İlknur Merve TÜRKYILMAZ BUĞAN Pınar YILDIZ
- 18 April 2025
- Published by Academician Publishing
Open AccessGüncel Kadın Hastalıkları ve Doğum Çalışmaları IX (Bahar)
Gebelikte Karaciğer Hastalıkları Abdulmecit ÖKTEM Endometrium Kanseri, Sirkadiyen Ritim ve Kronokemoterapi Yağmur SOYKAN Atiye Seda YAR SAĞLAM Tubal ve Non-Tubal Ektopik Gebelikler Hayal UZELLI ŞIMŞEK Anormal Uterin Kanama Meryem Özge ÇAKIR NEMLİ V-Notes Histerektomi: Minimal İnvaziv Bir Yaklaşım Serhat SARIKAYA Polikistik Over Sendromu Tedavisinde Kullanılma Özelliği Olan Bazı Bitkiler Derya UÇAR Ömer KILIÇ Talip ŞAHİN Tekrarlayan Gebelik Kayıpları: İmmünolojik, Genetik ve Anatomik Faktörler Mehmet Efe NAMLI Fetal Kas-İskelet Sistemi Serhat AKCAN Fetal Santral Sinir Sistemi Serhat AKCAN Gebelik ve Hipotiroidizm Çağlayan BIÇER Fatih AKKUŞ Ektopik Gebelik Selin MUTLU Endometriozis Selin MUTLU Gebelikte Hipertiroidizm; Klinik Bulgular, Tanı ve Tedavi Raziye TORUN Prenatal Kayıp ve Hemşirelik Bakımı Merve YAZAR Gül Büşra ALTUNAY Servikal Yetmezlik İlayda GERCİK ARZIK Korea Gravidarum Hale ANKARA AKTAŞ Gebelik ve Addison Hastalığı İlknur TOKA Konjenital Zika Virüs Enfeksiyonu Ceren SAĞLAM Progesteron Tedavisinin Hormon Düzeyleri ve Solunum Fonksiyonları Üzerindeki Etkileri: Polikistik Over Sendromlu Hastalarda Klinik Bir Çalışma Fikriye KARANFIL Aybike PEKIN Kazım GEZGINÇ Rengin KARATAYLI Emin MADEN Rh İzoimmünizasyonu İlknur Merve TÜRKYILMAZ BUĞAN Pınar YILDIZ
- 10 October 2019
- Published by Galenos Yayinevi in Journal of Turkish Society of Obstetric and Gynecology
- Vol. 16 (3) , 158-163
Surgical risk assessment for gynecological oncologic patients
Preoperative surgical risk assessment is important in terms of postoperative morbidity and mortality. Therefore, it is necessary to evaluate the efficacy and safety of these surgeries via an ideal risk assessment model, and reduce risks via applying some findings (for instance, perioperative beta-blockers). There are some risk assessment systems, but these have generally not been verified for patients with gynecologic cancer. The aim of this study was to assess the risk of surgery for gynecological oncologic patients and suggest an easy risk assessment model and risk reduction by applying our findings. We retrospectively analyzed 258 gynecologic patients with cancer. Age, diagnosis, staging, performance scale, metoprolol use, heart, renal diabetes, Chronic Obstructive Pulmonary disease, diabetes, operation type and length, carcinoma antigen 125, ascites, albumin, surgical procedure, hospitalization length, and complications were recorded. Of the 258 patients, 173 patients (67.1%) had no complications, 43 patients (16.7%) had one and 42 patients (16.3%) had two or more complications. The most common complication was the acid-base imbalance (14%), followed by urinary tract infection (9.7%). Parameters associated with complications were performance status, ascites, operating length, metoprolol use, and upper abdominal surgery. In our proposed scoring model with a total score range 0-23, cut-off value points for both the presence and rate of complications was found as >5. In gynecological patients with cancer, the addition of metoprolol use and upper abdominal surgery within preoperative risk assessment evaluation parameters are significantly effective in predicting the rate and severity of complications. Moreover, we have suggested a simple, practical, and convenient scoring model for this evaluation.
- 10 October 2019
- Published by Galenos Yayinevi in Journal of Turkish Society of Obstetric and Gynecology
- Vol. 16 (3) , 158-163
Surgical risk assessment for gynecological oncologic patients
Preoperative surgical risk assessment is important in terms of postoperative morbidity and mortality. Therefore, it is necessary to evaluate the efficacy and safety of these surgeries via an ideal risk assessment model, and reduce risks via applying some findings (for instance, perioperative beta-blockers). There are some risk assessment systems, but these have generally not been verified for patients with gynecologic cancer. The aim of this study was to assess the risk of surgery for gynecological oncologic patients and suggest an easy risk assessment model and risk reduction by applying our findings. We retrospectively analyzed 258 gynecologic patients with cancer. Age, diagnosis, staging, performance scale, metoprolol use, heart, renal diabetes, Chronic Obstructive Pulmonary disease, diabetes, operation type and length, carcinoma antigen 125, ascites, albumin, surgical procedure, hospitalization length, and complications were recorded. Of the 258 patients, 173 patients (67.1%) had no complications, 43 patients (16.7%) had one and 42 patients (16.3%) had two or more complications. The most common complication was the acid-base imbalance (14%), followed by urinary tract infection (9.7%). Parameters associated with complications were performance status, ascites, operating length, metoprolol use, and upper abdominal surgery. In our proposed scoring model with a total score range 0-23, cut-off value points for both the presence and rate of complications was found as >5. In gynecological patients with cancer, the addition of metoprolol use and upper abdominal surgery within preoperative risk assessment evaluation parameters are significantly effective in predicting the rate and severity of complications. Moreover, we have suggested a simple, practical, and convenient scoring model for this evaluation.